Jefferies Group's IDXX Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 20,072 shares of IDEXX Laboratories, Inc. (IDXX) worth $13.58 M, representing 0.07% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in IDXX, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2023, adding 16,915 shares. Largest reduction occurred in Q1 2025, reducing 7,067 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's IDEXX Laboratories (IDXX) Holding Value Over Time
Track share changes against reported price movement
Quarterly IDEXX Laboratories (IDXX) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -393 | Reduce 1.92% | 20,072 | $676.53 |
| Q3 2025 | -1,173 | Reduce 5.42% | 20,465 | $638.89 |
| Q2 2025 | +2,099 | Add 10.74% | 21,638 | $536.34 |
| Q1 2025 | -7,067 | Reduce 26.56% | 19,539 | $419.95 |
| Q4 2024 | +14,711 | Add 123.67% | 26,606 | $413.44 |
| Q3 2024 | +635 | Add 5.64% | 11,895 | $505.22 |
| Q2 2024 | -1,880 | Reduce 14.31% | 11,260 | $487.20 |
| Q1 2024 | -6,793 | Reduce 34.08% | 13,140 | $539.93 |
| Q4 2023 | +16,915 | Add 560.47% | 19,933 | $555.05 |
| Q3 2023 | +1,381 | Add 84.36% | 3,018 | $437.27 |
| Q2 2023 | -4,201 | Reduce 71.96% | 1,637 | $502.23 |
| Q1 2023 | +138 | Add 2.42% | 5,838 | $500.08 |
| Q4 2022 | +5,700 | New Buy | 5,700 | $407.96 |
Jefferies Group's IDEXX Laboratories Investment FAQs
Jefferies Group first purchased IDEXX Laboratories, Inc. (IDXX) in Q4 2022, acquiring 5,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held IDEXX Laboratories, Inc. (IDXX) for 13 quarters since Q4 2022.
Jefferies Group's largest addition to IDEXX Laboratories, Inc. (IDXX) was in Q4 2023, adding 19,933 shares worth $11.06 M.
According to the latest 13F filing for Q4 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 20,072 shares of IDEXX Laboratories, Inc. (IDXX), valued at approximately $13.58 M.
As of the Q4 2025 filing, IDEXX Laboratories, Inc. (IDXX) represents approximately 0.07% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in IDEXX Laboratories, Inc. (IDXX) was 26,606 shares, as reported at the end of Q4 2024.